Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Asset disposition
Director departure
|
|
ENZON PHARMACEUTICALS, INC. (ENZN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| READ RANDOLPH C (Director) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 15,000 shares
@ $0.1325, valued at
$2k
Bought 84,550 shares
@ $0.141, valued at
$11.9k
|
|
| 08/17/2021 |
4
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Sold 50,000 shares
@ $0.3898, valued at
$19.5k
Sold 57,500 shares
@ $0.3898, valued at
$22.4k
|
|
| 11/18/2020 |
4
| READ RANDOLPH C (Director) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 50,450 shares
@ $0.1511, valued at
$7.6k
Bought 50,000 shares
@ $0.1575, valued at
$7.9k
|
|
| 11/17/2020 |
4
| Bleznick Jordan (Director) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 100,000 shares
@ $0.1538, valued at
$15.4k
|
|
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 15,500 shares
@ $0.25, valued at
$3.9k
Bought 10,000 shares
@ $0.25, valued at
$2.5k
Bought 500 shares
@ $0.25, valued at
$125
Bought 10,000 shares
@ $0.25, valued at
$2.5k
Bought 5,000 shares
@ $0.25, valued at
$1.3k
|
|
| 01/09/2019 |
4
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 20,600 shares
@ $0.255, valued at
$5.3k
Bought 8,800 shares
@ $0.2588, valued at
$2.3k
Bought 67,200 shares
@ $0.26, valued at
$17.5k
Bought 100,000 shares
@ $0.21, valued at
$21k
Bought 100,000 shares
@ $0.21, valued at
$21k
Bought 2,500 shares
@ $0.21, valued at
$525
Bought 15,000 shares
@ $0.2196, valued at
$3.3k
Bought 40,050 shares
@ $0.22, valued at
$8.8k
Bought 42,450 shares
@ $0.22, valued at
$9.3k
Bought 450 shares
@ $0.22, valued at
$99
Bought 1,100 shares
@ $0.22, valued at
$242 |
|
| 01/09/2019 |
4
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 4,700 shares
@ $0.26, valued at
$1.2k
Bought 185,700 shares
@ $0.26, valued at
$48.3k
Bought 3,000 shares
@ $0.26, valued at
$780
Bought 33,500 shares
@ $0.26, valued at
$8.7k
Bought 55,000 shares
@ $0.26, valued at
$14.3k
Bought 4,000 shares
@ $0.26, valued at
$1k
Bought 20,200 shares
@ $0.26, valued at
$5.3k
Bought 50,000 shares
@ $0.26, valued at
$13k
Bought 5,500 shares
@ $0.26, valued at
$1.4k
Bought 1,000 shares
@ $0.26, valued at
$260
Bought 2,000 shares
@ $0.26, valued at
$520 |
|
| 11/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2014 |
4
| ICAHN CARL C (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 694,023 shares
@ $0
Disposed of 694,023 shares
@ $0
Exercised (in-or-at-the-money) 694,023 shares
@ $0
Disposed of 694,023 shares
@ $0
Exercised (in-or-at-the-money) 1 options to buy
@ $11.14, valued at
$11.1
Acquired 1 options to buy
@ $6.31, valued at
$6.3
Exercised (in-or-at-the-money) 1 options to buy
@ $6.31, valued at
$6.3
Acquired 1 options to buy
@ $1.09, valued at
$1.1 |
|
| 09/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2013 |
4
| Rackear Andrew D. (VP and General Counsel) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 4,686 shares
@ $0 |
|
| 01/25/2013 |
4
| Buchbinder Aby (VP, Clinical Development) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 3,748 shares
@ $0 |
|
| 01/25/2013 |
4
| Conover Charles (SVP, R&D Program Management) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 2,343 shares
@ $0 |
|
| 01/04/2013 |
4
| Young Richard A (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 20,129 options to buy
@ $4.54, valued at
$91.4k
|
|
| 01/04/2013 |
4
| Deuel Thomas (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 20,129 options to buy
@ $4.54, valued at
$91.4k
|
|
| 01/04/2013 |
4
| SALISBURY ROBERT C (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 20,129 options to buy
@ $4.54, valued at
$91.4k
|
|
| 01/04/2013 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 35,226 options to buy
@ $4.54, valued at
$159.9k
|
|
| 01/04/2013 |
4
| LEBUHN ROBERT (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 20,129 options to buy
@ $4.54, valued at
$91.4k
|
|
| 01/04/2013 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 40,258 options to buy
@ $4.54, valued at
$182.8k
|
|
| 11/08/2012 |
4
| HEBARD GEORGE (Interim PEO and Interim COO) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 24,500 shares
@ $0
Granted 73,500 options to buy
@ $6.18, valued at
$454.2k
|
|
| 08/15/2012 |
4
| LEBUHN ROBERT (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Sold 5,820 shares
@ $6.5821, valued at
$38.3k
|
|
| 08/13/2012 |
4
| LEBUHN ROBERT (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Sold 1,933 shares
@ $6.5802, valued at
$12.7k
|
|
| 07/03/2012 |
4
| Young Richard A (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 10,669 shares
@ $0 |
|
| 07/03/2012 |
4
| SALISBURY ROBERT C (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 10,669 shares
@ $0 |
|
| 07/03/2012 |
4
| LEBUHN ROBERT (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 10,669 shares
@ $0 |
|
| 07/03/2012 |
4
| Deuel Thomas (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 10,669 shares
@ $0 |
|
| 07/03/2012 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 18,670 shares
@ $0 |
|
| 07/03/2012 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 21,338 shares
@ $0 |
|
| 06/21/2012 |
4
| HEBARD GEORGE (Interim PEO and Interim COO) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $6.879, valued at
$34.4k
|
|
| 06/06/2012 |
4
| Rackear Andrew D. (VP and General Counsel) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Sold 1,614 shares
@ $6.805, valued at
$11k
|
|
|
|
|